(Q39694999)

English

Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells

scientific article published on June 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 September 2017

Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells (English)

1 reference

Europe PubMed Central

14 September 2017

0 references

1 reference

based on heuristic

inferred from title

Alejandro Romero Martínez

1

1 reference

Europe PubMed Central

14 September 2017

object named as

Javier Egea

2

0 references

object named as

Manuela G López

4

0 references

Antonio G. García

object named as

Antonio G García

3

0 references

publication date

1 June 2010

1 reference

Europe PubMed Central

14 September 2017

Journal of Pineal Research

1 reference

Europe PubMed Central

14 September 2017

49

1 reference

Europe PubMed Central

14 September 2017

2

1 reference

Europe PubMed Central

14 September 2017

141-148

1 reference

Europe PubMed Central

14 September 2017

Oxidative stress, cell cycle, and neurodegeneration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Oxidative stress mechanisms and potential therapeutics in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Indicators of neuroprotection with galantamine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Reduced oxidative damage in ALS by high-dose enteral melatonin treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Melatonin prevents oxidative stress resulting from iron and erythropoietin administration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Melatonin improves oxidative stress parameters measured in the blood of elderly type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Cytotoxicity of 1,2-diacetylbenzene in human neuroblastoma SHSY5Y cells is mediated by oxidative stress.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Modulation of tyrosine hydroxylase expression by melatonin in human SH-SY5Y neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Alzheimer's disease: new approaches to drug discovery

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

A small molecule targeting the multifactorial nature of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Combination therapy in Alzheimer's disease: a review of current evidence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Melatonin: reducing the toxicity and increasing the efficacy of drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Galantamine and memantine produce different degrees of neuroprotection in rat hippocampal slices subjected to oxygen-glucose deprivation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Effects of memantine and galantamine given separately or in association, on memory and hippocampal neuronal loss after transient global cerebral ischemia in gerbils

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Galantamine postischemia provides neuroprotection and memory recovery against transient global cerebral ischemia in gerbils.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Galantamine modulates nicotinic receptor and blocks Abeta-enhanced glutamate toxicity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Evidence of prooxidant and antioxidant action of melatonin on human liver cell line HepG2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Cytoprotective effects of melatonin on C6 astroglial cells exposed to glutamate excitotoxicity and oxidative stress

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Sustained phosphorylation of tyrosine hydroxylase at serine 40: a novel mechanism for maintenance of catecholamine synthesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Regulation of antioxidant enzymes: a significant role for melatonin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Distinct protective mechanisms of HO-1 and HO-2 against hydroperoxide-induced cytotoxicity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00778.X

21 January 2018

Identifiers

10.1111/J.1600-079X.2010.00778.X

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39694999&oldid=2088890048"